BICARA THERAPEUTICS INC (BCAX) Stock Income Statement
NASDAQ:BCAX - US0554771032 - Common Stock
12.06 USD
+0.06 (+0.5%)
12.06 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 121.07M | 82.39M | 39.89M | 37.66M | |||
| Research and Development | 94.88M | 63.62M | 30.62M | 31.31M | |||
| Selling, General, and Administrative Expenses | 26.19M | 18.77M | 9.27M | 6.34M | |||
| Operating Income | -121.07M | -82.39M | -39.89M | -37.66M | |||
| Interest Income/Expense | 18.71M | 14.58M | 1.31M | -108.00K | |||
| Other Income/Expense | N/A | 0.00 | -13.40M | -80.00K | |||
| Income Before Taxes | -102.36M | -67.81M | -51.98M | -37.84M | |||
| Income Tax | 310.00K | 187.00K | 5.00K | 1.00K | |||
| Net Income | -102.67M | -68.00M | -51.98M | -37.84M | |||
| EBITDA | -121.00M | -82.33M | -39.87M | -37.65M | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -4.69 | -4.05 | -1.00 | -0.73 | |||
| Non GAAP EPS | -3.17 | N/A | N/A | N/A | |||
| Statistics | |||||||
All data in USD